Advancing Guideline-Directed Care in Hypertrophic Cardiomyopathy

Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before.

To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for identifying predisposition for genetic heart disease and sudden death, which can be lifesaving for some patients, the Heart Rhythm Society developed a webinar to increase awareness and adoption of guideline directed care for the diagnosis and treatment of patients with hypertrophic cardiomyopathy (HCM).

Upon completion of this complimentary, 1-COP credit webinar, the learner will be able to: Describe the growing role of genetic testing in clinical practice for patients with HCM, Discuss how genetic testing fits in to multidisciplinary care of the patient with HCM, and Discuss barriers to referral for genetic testing and possible solutions.